Similar to the combined set of breast cancer samples of all subtypes, the MKK3 overexpression correlates with poor survival of TNBC Black/African American patients (p < 0.001, Fig. 4h), but not White patients (p = 0.582, Fig. 4i). This evidence concerns the gene MAP2K3 and breast cancer.